Cancer recurrence or aggravation following COVID-19 vaccination

A tétel rövid nézete
dc.contributor.authorSoleimani, Parisa
dc.contributor.authorYadollahifarsani, Sepideh
dc.contributor.authorMotieian, Mahsa
dc.contributor.authorChenarani Moghadam, Mahshid Sadat
dc.contributor.authorAlimohammadi, Shahrzad
dc.contributor.authorKhayyat, Azadeh
dc.contributor.authorEsmaeil Pour, Mohammad Ali
dc.contributor.authorNeshat, Sina
dc.contributor.authorMarashi, Narges Alsadat
dc.contributor.authorMahmoodnia, Leila
dc.contributor.authorMasomi, Rohollah
dc.contributor.authorAlimohammadi, Shahrzad (1991-) (Gyógyszerész)
dc.contributor.authorAlimohammadi, Shahrzad (1991-) (Gyógyszerész)
dc.contributor.submitterdepImmunológiai Intézet -- 18
dc.contributor.submitterdepÁOK
dc.contributor.submitterdepDebreceni Egyetem
dc.contributor.submitterdepDebreceni Egyetem - Molekuláris Orvostudomány Doktori Iskola
dc.date.accessioned2023-07-19T06:17:16Z
dc.date.available2023-07-19T06:17:16Z
dc.date.oa2023-08-07
dc.date.updated2023-07-19T06:17:15Z
dc.description.abstractCOVID-19 infection has been a global health issue in the past recent years and numerous topics are studied in order to discover its pathophysiology and potential side effects. The potential for disease recurrence following the administration of the COVID-19 vaccine is one of the issues that has recently attracted attention. Several studies have revealed that the COVID-19 vaccines, like other vaccines, may have side effects and, in some cases, they may even deteriorate the underlying illnesses, such as rheumatic diseases, autoimmune diseases, and cancers. The effectiveness and safety of the COVID-19 vaccine for patients with malignancies are one of the factors that are considered regarding this vaccine. Lymph node involvement, disease recurrence, and potential paraclinical changes after receiving the COVID-19 vaccine are some of the concerns of patients with malignancy. In this mini-review, we attempted to investigate cases of cancer recurrence or recovery as well as lymphadenopathy following vaccination.
dc.description.correctorkzs
dc.identifier.citationJournal of Nephropharmacology. -12 : 2 (2023), p. 1-8 (cikkazonosító)e10593. -J Nephropharmacol. -2345-4202
dc.identifier.doi10.34172/npj.2023.10593
dc.identifier.issn2345-4202
dc.identifier.opachttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM113526
dc.identifier.urihttps://hdl.handle.net/2437/357666
dc.identifier.urlhttps://jnephropharmacology.com/Article/npj-10593
dc.languageeng
dc.rights.accessopen access article
dc.rights.ownerszerző
dc.subject.otheridegen nyelvű folyóiratközlemény külföldi lapban
dc.subject.otherCancer, Malignancy, COVID-19 vaccine, SARS-CoV-2, Cancer
dc.titleCancer recurrence or aggravation following COVID-19 vaccination
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nem elérhető
Név:
FILE_UP_1_Cancer recurrence or aggravation.pdf
Méret:
380.4 KB
Formátum:
Adobe Portable Document Format
Leírás:
kiadói változat
Letöltés
Gyűjtemények
Publikációs Adatbázis